Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
OliX Pharmaceuticals Logo
OliX Pharmaceuticals Growth Score
94
CB Rank
23566
Heat Score
93
OliX is a clinical stage biotechnology company.
Founded
obfuscation
PublicPost-IPO Equity Suwon, Ch'ungch'ong-namdo, South Korea51-100 olixpharma.com
Biotechnology
Medical
Pharmaceutical
Overview

OliX Pharmaceuticals
Total Funding
obfuscation
Growth Score
94
Heat Score
93

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score94
7 pts
in past quarter
Heat Score 93
30 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About OliX Pharmaceuticals

CB Rank
23566
OliX is a clinical stage biotechnology company.
Founded
obfuscation
PublicPost-IPO Equity Suwon, Ch'ungch'ong-namdo, South Korea51-100 olixpharma.com
Biotechnology
Medical
Pharmaceutical

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name OliX Pharmaceuticals, Inc.
Also Known As 올릭스
Operating Status Active
Stock Symbol  KOSDAQ:226950
Company Type For Profit
Founders  Dong-ki Lee
About the Company
OliX is a clinical stage biotechnology company, based on their own proprietary RNA interference (RNAi) technology regulating the expression of disease-causing genes.
Phone Number +82-031-779-8400
Contact Email olixpharma@olixpharma.com
Predictions & Insights

Growth Insight

See this Growth Insight
OliX Pharmaceuticals is
Lorem
 to be growing
Top Contributing Factors
Financial Growth

Products & Services

OLX101A
A treatment designed to inhibit the formation of hypertrophic and keloid scars by targeting the CTGF gene, reducing collagen production.
OLX301A
A treatment for both dry and wet age-related macular degeneration, targeting genes responsible for retinal pigment epithelial cell damage.

Research & Development

OliX Pharmaceuticals is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - OliX Pharmaceuticals Logo
Post-IPO Equity - OliX Pharmaceuticals
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - OliX Pharmaceuticals Logo
Post-IPO Equity - OliX Pharmaceuticals
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - OliX Pharmaceuticals Logo
Post-IPO Equity - OliX Pharmaceuticals
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - OliX Pharmaceuticals Logo
Post-IPO Equity - OliX Pharmaceuticals
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - OliX Pharmaceuticals Logo
Post-IPO Equity - OliX Pharmaceuticals
2
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - OliX Pharmaceuticals Logo
Post-IPO Equity - OliX Pharmaceuticals
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - OliX Pharmaceuticals Logo
Post-IPO Equity - OliX Pharmaceuticals
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - OliX Pharmaceuticals Logo
Post-IPO Equity - OliX Pharmaceuticals
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - OliX Pharmaceuticals Logo
Post-IPO Equity - OliX Pharmaceuticals
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - OliX Pharmaceuticals Logo
Post-IPO Equity - OliX Pharmaceuticals
2
obfuscation
— Post-IPO Equity

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 51-100 Employee Profiles 3 Contacts 14

Employee Profiles

News

News and Press

News•Jun 6, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 5, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 3, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jul 16, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

522
-96.57%
 in past month

Interest Signals

TopicSurge Score
Producer Management System Logo
Producer Management System
88
Cloud Co-Selling Logo
Cloud Co-Selling
84
Data Center Strategy Logo
Data Center Strategy
84

Active Website Tech Count

5OliX Pharmaceuticals is actively using 5 technologies for its website, according to BuiltWith. These include SPF, DMARC, and  YouTube.

Total IP

48The intellectual property of OliX Pharmaceuticals includes 45 registered patents primarily in the 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering' category, according to IPqwery. Additionally, OliX Pharmaceuticals has registered 3 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is OliX Pharmaceuticals's headquarters? OliX Pharmaceuticals is located in Suwon, Ch'ungch'ong-namdo, South Korea.Who invested in OliX Pharmaceuticals? OliX Pharmaceuticals has 8 investors including Weiss Asset Management and  Business Opportunities for L'Oréal Development.When was the last funding round for OliX Pharmaceuticals? OliX Pharmaceuticals closed its last funding round on
obfuscation
from a Post-IPO Equity round.How much funding has OliX Pharmaceuticals raised to date? OliX Pharmaceuticals has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(c22f898 1)
|